145 related articles for article (PubMed ID: 9245566)
1. Candida albicans and Escherichia coli are synergistic pathogens during experimental microbial peritonitis.
Klaerner HG; Uknis ME; Acton RD; Dahlberg PS; Carlone-Jambor C; Dunn DL
J Surg Res; 1997 Jul; 70(2):161-5. PubMed ID: 9245566
[TBL] [Abstract][Full Text] [Related]
2. The role of Candida albicans in the pathogenesis of experimental fungal/bacterial peritonitis and abscess formation.
Sawyer RG; Adams RB; Rosenlof LK; May AK; Pruett TL
Am Surg; 1995 Aug; 61(8):726-31. PubMed ID: 7618816
[TBL] [Abstract][Full Text] [Related]
3. Development of Candida albicans and C. albicans/Escherichia coli/Bacteroides fragilis intraperitoneal abscess models with demonstration of fungus-induced bacterial translocation.
Sawyer RG; Adams RB; May AK; Rosenlof LK; Pruett TL
J Med Vet Mycol; 1995; 33(1):49-52. PubMed ID: 7650578
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis. IV. The adjuvant effect of hemoglobin in granulocytopenic rats.
Hau T; Lee JT; Simmons RL
Surgery; 1981 Feb; 89(2):187-91. PubMed ID: 7006133
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of fluconazole in murine Candida albicans and bacterial C. albicans peritonitis and abscess formation.
Sawyer RG; Adams RB; Rosenlof LK; May AK; Pruett TL
J Med Vet Mycol; 1995; 33(2):131-6. PubMed ID: 7658305
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of the adjuvant effect of hemoglobin in experimental peritonitis: VIII. A leukotoxin is produced by Escherichia coli metabolism in hemoglobin.
Pruett TL; Rotstein OD; Fiegel VD; Sorenson JJ; Nelson RD; Simmons RL
Surgery; 1984 Aug; 96(2):375-83. PubMed ID: 6379961
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of the adjuvant effect of hemoglobin in experimental peritonitis. IX: The infection-potentiating effect of hemoglobin in Escherichia coli peritonitis is strain specific.
Pruett TL; Rotstein OD; Wells CL; Sorenson JJ; Simmons RL
Surgery; 1985 Sep; 98(3):371-7. PubMed ID: 2412304
[TBL] [Abstract][Full Text] [Related]
8. Bile increases lipopolysaccharide release in experimental E. coli peritonitis.
Andersson R; Sonesson A; Larsson L; Schalén C; Tranberg KG
Eur J Surg; 1991 Feb; 157(2):117-20. PubMed ID: 1676304
[TBL] [Abstract][Full Text] [Related]
9. Mortality in murine peritonitis correlates with increased Escherichia coli adherence to the intestinal mucosa.
Burch PT; Scott MJ; Wortz GN; Peyton JC; Cheadle WG
Am Surg; 2004 Apr; 70(4):333-41. PubMed ID: 15098788
[TBL] [Abstract][Full Text] [Related]
10. Role of host and bacterial virulence factors in Escherichia coli spontaneous bacterial peritonitis.
Cereto F; Herranz X; Moreno E; Andreu A; Vergara M; Fontanals D; Roget M; Simó M; González A; Prats G; Genescà J
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):924-9. PubMed ID: 18794608
[TBL] [Abstract][Full Text] [Related]
11. Absence of direct relationship between intraperitoneal cellular influx and resistance to experimental peritonitis.
Van Geertruyden N; De Wilde JP; Bournonville B; Struelens M; Kinnaert P
Acta Chir Belg; 1998 Aug; 98(4):148-53. PubMed ID: 9779236
[TBL] [Abstract][Full Text] [Related]
12. Parameters for determination of Candida albicans virulence in murine peritonitis.
Kretschmar M; Bertsch T; Göller M; Schaller M; Hof H; Nichterlein T
Mycoses; 1999; 42 Suppl 2():19-24. PubMed ID: 10865898
[TBL] [Abstract][Full Text] [Related]
13. Polyethylene glycol influences microbial interactions with intestinal epithelium.
Henry-Stanley MJ; Wells CL
Shock; 2009 Apr; 31(4):390-6. PubMed ID: 18665048
[TBL] [Abstract][Full Text] [Related]
14. Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice.
Khan MA; Nasti TH; Saima K; Mallick AI; Firoz A; Wajahul H; Ahmad N; Mohammad O
FEMS Immunol Med Microbiol; 2004 Jul; 41(3):249-58. PubMed ID: 15196575
[TBL] [Abstract][Full Text] [Related]
15. Endotoxin promotes synergistic lethality during concurrent Escherichia coli and Candida albicans infection.
Burd RS; Raymond CS; Dunn DL
J Surg Res; 1992 Jun; 52(6):537-42. PubMed ID: 1528027
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Silvestri C; Di Matteo F; Abbruzzetti A; Scalise G; Saba V
Crit Care Med; 2008 Jan; 36(1):240-5. PubMed ID: 18090372
[TBL] [Abstract][Full Text] [Related]
17. [Pathogenicity of some microorganisms for chicken gnotobiotes].
Moskalik RS; Nikolaeva AV
Veterinariia; 1976 Mar; (3):57-8. PubMed ID: 775762
[No Abstract] [Full Text] [Related]
18. [Changes in tissue plasminogen activator in experimental peritonitis caused by pathogenic factors].
Karoń J; Zozulińska M; Grzywacz A; Pawlaczyk K; Połubińska A
Wiad Lek; 1997; 50 Suppl 1 Pt 2():259-63. PubMed ID: 9424884
[TBL] [Abstract][Full Text] [Related]
19. Liver lipid peroxidation in experimental Escherichia coli peritonitis: the role of myeloperoxidase and nitric oxide inhibition.
Demir M; Sert S; Kaleli I; Demir S; Cevahir N; Yildirim U; Sahin B
Med Sci Monit; 2007 Oct; 13(10):BR225-9. PubMed ID: 17901846
[TBL] [Abstract][Full Text] [Related]
20. Case report 3: Colorectal cancer patient.
Borges Sa M
Mycoses; 2010 Jul; 53 Suppl 2():8-9. PubMed ID: 20591013
[No Abstract] [Full Text] [Related]
[Next] [New Search]
